In this issue of the Revista Brasileira de Terapia Intensiva, Rios et al.^([@r01])^ demonstrate the effects of volume replacement with hypertonic saline solution (HSS) on hepatic cytokine production and expression of heat-shock proteins and apoptotic proteins in an animal model of acute pancreatitis. HSS down-regulated liver cytokine production and HSP60 expression in a more robust manner when compared to normal saline solution.

More than 30 years have passed since the first description of HSS as a resuscitation solution in hemorrhagic shock.^([@r02])^ HSS can exert its beneficial effects by mobilizing fluids from intracellular to extracellular compartments and by improving myocardial contractility and microcirculatory flow.^([@r03])^ In addition, it may have immunomodulatory effects.^([@r03])^ Thus, the original rationale based on its osmotic effect that enables small volume resuscitation in hypovolemic shock^([@r02])^ and decreases brain edema after traumatic brain injury^([@r04])^ may be too simplistic. The results presented by Rios et al.^([@r01])^ add to previous demonstrations of benefit from HSS on several different aspects of inflammation and organ function in pre-clinical models of systemic inflammatory response syndrome (SIRS) and sepsis.^([@r03])^ However, human trials have failed to provide convincing evidence of efficacy.^([@r05])^ Clearly this potential needs to be examined further, particularly as it is cheap and widely available, but we should wait until more robust clinical data are available.
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